For Providers

How Has Allergychoices Changed the Way You Treat Allergy?

"We now offer to our patients both allergy drops as well as allergy shots, with a high recommendation towards allergy drops..."

Provider review

Watch the review

Reviewed by

— Lorraine Williams, MD, FACS, ENT, Georgia

In their own words

“Basically, we now offer to our patients both allergy drops as well as allergy shots, with a high recommendation towards allergy drops for all of the reasons we mentioned before. It’s easier. Even though it’s three times a day it’s much more tolerable for patients. They don’t get stuck. It’s less costly for commercial patients as well because they don’t have a copay every week.

“It has really broadened the way we treat allergy in terms of offering it to more patients. In addition, allergy drops tend to have a lower reactivity rate, so there are less patients having anaphylaxis in your office. It tends to be much safer in your office and an opportunity to just broaden the scope of what you do.”

Keep watching

More provider reviews

Next step

Tired of seeing your allergy patients suffer?

Call us at (866) 793-1680 or fill out this form to discuss offering this safe and effective option!

Regulatory status of allergy drops

A small number of sublingual immunotherapy (SLIT) tablets are FDA-approved for specific allergens. Personalized allergy drops are compounded by a pharmacy for each patient and prescribed off-label — a long-standing, legitimate practice with decades of use, and SLIT is a first-line prescription approach in much of Europe. Compounded allergy drops are not FDA-approved, but they are created using FDA-approved allergenic extracts, the same as in allergy shots. Off-label does not mean unsafe or experimental.

U.S. allergenic extracts are licensed and labeled for injection and skin testing, not for the sublingual route, so prescribing them as sublingual drops is an off-label clinical decision made by the treating provider.